Drugs in the Pipeline
Phase 3 study of Avastin for the treatment of ovarian cancer
Genentech announced results from its Phase 3 study of Avastin (bevacizumab) in combination with chemotherapy (carboplatin and gemcitabine) for the treatment of previously treated (recurrent), platinum-sensitive ovarian cancer.